Cadherin switch in tumor progression

Annals of the New York Academy of Sciences

Volumn 1014, Issue , 2004, Pages 155-163

  Hazan, Rachel B ^a   Qiao, Rui ^b   Keren, Rinat ^a   Badano, Ines ^a   Suyama, Kimita ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Adhesion; Cadherin; Carcinoma

Indexed keywords

CADHERIN; CELL ADHESION MOLECULE; NERVE CELL ADHESION MOLECULE; UVOMORULIN;

BREAST CANCER; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CELL MOTILITY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MESENCHYME; METASTASIS; MODULATION; MOLECULAR MECHANICS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH;

EID: 2342556584     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1294.016     Document Type: Review

References (57)

1. TAKEICHI, M. 1990. Cadherins: a molecular family important in selective cell-cell adhesion. Annu. Rev. Biochem. 59: 237-252.
2. TAKEICHI, M. 1993. Cadherins in cancer: implications for invasion and metastasis. Curr. Opin. Cell Biol. 5: 806-811.
3. BIRCHMEIER, W. & J. BEHRENS. 1994. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim. Biophys. Acta 1198: 11-26.
4. KEMLER, R. 1992. Classical cadherins. Semin. Cell Biol. 3: 149-155.
5. TANIHARA, H. et al. 1994. Cloning of five human cadherins clarifies characteristic features of cadherin extracellular domain and provides further evidence for two structurally different types of cadherin. Cell Adhes. Commun. 2: 15-26.
6. TANIHARA, H. et al. 1994. Characterization of cadherin-4 and cadherin-5 reveals new aspects of cadherins. J. Cell Sci. 107 (Pt 6): 1697-1704.
7. TAKEICHI, M. 1991. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251: 1451-1455.
8. HATTA, K. et al. 1987. Spatial and temporal expression pattern of N-cadherin cell adhesion molecules correlated with morphogenetic processes of chicken embryos. Dev. Biol. 120: 215-227.
9. HATTA, K. & M. TAKEICHI. 1986. Expression of N-cadherin adhesion molecules associated with early morphogenetic events in chick development. Nature 320: 447-449.
10. REDIES, C. & M. TAKEICHI. 1993. Expression of N-cadherin mRNA during development of the mouse brain. Dev. Dyn. 197: 26-39.
11. BIXBY, J.L. & R. ZHANG. 1990. Purified N-cadherin is a potent substrate for the rapid induction of neurite outgrowth. J. Cell Biol. 110: 1253-1260.
12. SHAPIRO, L. et al. 1995. Structural basis of cell-cell adhesion by cadherins [see comments]. Nature 374: 327-337.
13. 2+ dependence and mutational analysis reveal molecular details of E-cadherin homoassociation. EMBO J. 18: 1738-1747.
14. OVERDUIN, M. et al. 1995. Solution structure of the epithelial cadherin domain responsible for selective cell adhesion. Science 267: 386-389.
15. GUMBINER, B.M. 1993. Proteins associated with the cytoplasmic surface of adhesion molecules. Neuron 11: 551-564.
16. OZAWA, M., M. RINGWALD & R. KEMLER. 1990. Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule. Proc. Natl. Acad. Sci. USA 87: 4246-4250.
17. WHEELOCK, M., K. KNUDSEN & K. JOHNSON. 1996. Membrane-cytoskeleton interactions with cadherin cell adhesion proteins: role of catenins as linker proteins. Curr. Top. Membr. 43: 169-185.
18. BRACKE, M., F.V. ROY & M. MAREEL. 1996. The E-cadherin/catenin complex in invasion and metastasis. In Attempts to Understand Metastasis Formation I. Metastasis-Related Molecules. U. Gunthert & W. Birchmeier, Eds. :123-161. Springer. Berlin.
19. BIRCHMEIER, W. et al. 1996. Epithelial differentiation and the control of metastasis in carcinomas. Curr. Top. Microbiol. Immunol. 213: 117-135.
20. CHRISTOFORI, G. & H. SEMB. 1999. The role of the cell-adhesion molecule E-cadherin as a tumour- suppressor gene. Trends Biochem. Sci. 24: 73-76.
21. BEHRENS, J. et al. 1989. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J. Cell Biol. 108: 2435-2447.
22. STERNLICHT, M.D. et al. 1999. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 98: 137-146.
23. FRIXEN, U.H. et al. 1991. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol. 113: 173-185.
24. VLEMINCKX, K. et al. 1991. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66: 107-119.
25. PERL, A.K. et al. 1998. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392: 190-193.
26. PEIFER, M. & P. POLAKIS. 2000. Wnt signaling in oncogenesis and embryogenesis: a look outside the nucleus. Science 287: 1606-1609.
27. CRAWFORD, H.C. et al. 1999. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene 18: 2883-2891.
28. GRADL, D., M. KUHL & D. WEDLICH. 1999. The Wnt/Wg signal transducer beta-catenin controls fibronectin expression. Mol. Cell Biol. 19: 5576-5587.
29. WONG, A.S. & B.M. GUMBINER. 2003. Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin. J. Cell Biol. 161: 1191-1203.
30. HAZAN, R.B. et al. 1997. N-cadherin promotes adhesion between invasive breast cancer cells and the stroma. Cell Adhes. Commun. 4: 399-411.
31. TOMITA, K. et al. 2000. Cadherin switching in human prostate cancer progression. Cancer Res. 60: 3650-3654.
32. HSU, M.Y. et al. 1996. Shifts in cadherin profiles between human normal melanocytes and melanomas. J. Invest. Dermatol. Symp. Proc. 1: 188-194.
33. SANDERS, D.S. et al. 1999. Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours. Mol. Pathol. 52: 151-157.
34. SANDIG, M. et al. 1997. Role of cadherins in the transendothelial migration of melanoma cells in culture. Cell. Motil. Cytoskel. 38: 351-364.
35. ISLAM, S. et al. 1996. Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion. J. Cell Biol. 135: 1643-1654.
36. NIEMAN, M.T. et al. 1999. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J. Cell Biol. 147: 631-644.
37. HAZAN, R.B. et al. 2000. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J. Cell Biol. 148: 779-790.
38. LEE, S.W. et al. 1998. H-cadherin expression inhibits in vitro invasiveness and tumor formation in vivo. Carcinogenesis 19: 1157-1159.
39. LEE, S.W. 1996. H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nat. Med. 2: 776-782.
40. TOYOOKA, K.O. et al. 2001. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. Cancer Res. 61: 4556-4560.
41. TOYOOKA, S. et al. 2002. Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas. Cancer Res. 62: 3382-3386.
42. SUYAMA, K. et al. 2002. A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell 2: 301-314.
43. KIM, J.B. et al. 2000. N-Cadherin extracellular repeat 4 mediates epithelial to mesenchymal transition and increased motility. J. Cell Biol. 151: 1193-1206.
44. WILLIAMS, E.J. et al. 1994. Activation of the FGF receptor underlies neurite outgrowth stimulated by L1, N-CAM, and N-cadherin. Neuron 13: 583-594.
45. FUJITA, Y. et al. 2002. Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat. Cell Biol. 4: 222-231.
46. JOAZEIRO, C.A. et al. 1999. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science 286: 309-312.
47. LEVKOWITZ, G. et al. 1999. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. Mol Cell. 4: 1029-1040.
48. BEHRENS, J. et al. 1993. Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadberin/beta-catenin complex in cells transformed with a temperature- sensitive v-SRC gene. J. Cell Biol. 120: 757-766.
49. HAMAGUCHI, M. et al. 1993. p60v-src causes tyrosine phosphorylation and inactivation of the N-cadherin-catenin cell adhesion system. EMBO J. 12: 307-314.
50. HAZAN, R.B. & L. NORTON. 1998. The epidermal growth factor receptor modulates the interaction of E-cadherin with the actin cytoskeleton. J. Biol. Chem. 273: 9078-9084.
51. VOURA, E.B., M. SANDIG & C.H. SIU. 1998. Cell-cell interactions during transendothelial migration of tumor cells. Microsc. Res. Tech. 43: 265-275.
52. KRAMER, R.H. & G.L. NICOLSON. 1979. Interactions of tumor cells with vascular endothelial cell monolayers: a model for metastatic invasion. Proc. Natl. Acad. Sci. USA 76: 5704-5708.
53. LI, G. et al. 2001. Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development. Oncogene 20: 8125-8135.
54. LI, G., K. SATYAMOORTHY & M. HERLYN. 2002. Dynamics of cell interactions and communications during melanoma development. Crit. Rev. Oral Biol. Med. 13: 62-70.
55. HSU, M.Y., F. MEIER & M. HERLYN. 2002. Melanoma development and progression: a conspiracy between tumor and host. Differentiation 70: 522-536.
56. CUNHA, G.R. & L.M. MATRISIAN. 2002. It's not my fault, blame it on my microenvironment. Differentiation 70: 469-472.
57. PISHVAIAN, M.J. et al. 1999. Cadherin-11 is expressed in invasive breast cancer cell lines. Cancer Res. 59: 947-952.